Roivant Sciences Ltd
NASDAQ:ROIV
Income Statement
Earnings Waterfall
Roivant Sciences Ltd
Revenue
|
123.2m
USD
|
Cost of Revenue
|
-15.3m
USD
|
Gross Profit
|
107.9m
USD
|
Operating Expenses
|
-1.2B
USD
|
Operating Income
|
-1.1B
USD
|
Other Expenses
|
5.5B
USD
|
Net Income
|
4.5B
USD
|
Income Statement
Roivant Sciences Ltd
Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||
Revenue |
24
N/A
|
30
+26%
|
43
+42%
|
61
+44%
|
55
-10%
|
52
-6%
|
50
-3%
|
43
-14%
|
61
+42%
|
79
+28%
|
103
+31%
|
123
+19%
|
|
Gross Profit | |||||||||||||
Cost of Revenue |
(2)
|
(3)
|
(8)
|
(9)
|
(9)
|
(10)
|
(7)
|
(9)
|
(13)
|
(16)
|
(15)
|
(15)
|
|
Gross Profit |
22
N/A
|
27
+26%
|
34
+26%
|
52
+52%
|
46
-11%
|
42
-9%
|
43
+3%
|
34
-22%
|
48
+43%
|
63
+31%
|
88
+40%
|
108
+23%
|
|
Operating Income | |||||||||||||
Operating Expenses |
(1 093)
|
(1 138)
|
(1 607)
|
(1 678)
|
(1 398)
|
(1 521)
|
(1 119)
|
(1 242)
|
(1 223)
|
(1 203)
|
(1 253)
|
(1 182)
|
|
Selling, General & Administrative |
(260)
|
(286)
|
(664)
|
(717)
|
(775)
|
(841)
|
(561)
|
(614)
|
(601)
|
(608)
|
(614)
|
(643)
|
|
Research & Development |
(833)
|
(853)
|
(1 010)
|
(961)
|
(623)
|
(680)
|
(558)
|
(628)
|
(623)
|
(625)
|
(639)
|
(539)
|
|
Other Operating Expenses |
0
|
0
|
66
|
0
|
0
|
0
|
0
|
0
|
0
|
29
|
0
|
0
|
|
Operating Income |
(1 071)
N/A
|
(1 111)
-4%
|
(1 572)
-42%
|
(1 626)
-3%
|
(1 352)
+17%
|
(1 480)
-9%
|
(1 076)
+27%
|
(1 208)
-12%
|
(1 175)
+3%
|
(1 140)
+3%
|
(1 165)
-2%
|
(1 075)
+8%
|
|
Pre-Tax Income | |||||||||||||
Interest Income Expense |
90
|
42
|
432
|
412
|
350
|
336
|
(196)
|
(129)
|
(17)
|
9
|
25
|
10
|
|
Non-Reccuring Items |
115
|
95
|
0
|
66
|
72
|
5
|
22
|
34
|
29
|
0
|
30
|
5 366
|
|
Total Other Income |
(33)
|
(19)
|
(25)
|
(48)
|
7
|
(34)
|
(11)
|
(34)
|
(62)
|
(70)
|
(105)
|
(35)
|
|
Pre-Tax Income |
(899)
N/A
|
(993)
-10%
|
(1 165)
-17%
|
(1 195)
-3%
|
(924)
+23%
|
(1 173)
-27%
|
(1 261)
-8%
|
(1 337)
-6%
|
(1 225)
+8%
|
(1 201)
+2%
|
(1 215)
-1%
|
4 266
N/A
|
|
Net Income | |||||||||||||
Tax Provision |
(2)
|
(1)
|
(0)
|
(1)
|
(0)
|
(4)
|
(6)
|
(9)
|
(5)
|
(3)
|
(5)
|
(27)
|
|
Income from Continuing Operations |
(900)
|
(993)
|
(1 165)
|
(1 196)
|
(924)
|
(1 177)
|
(1 267)
|
(1 346)
|
(1 230)
|
(1 204)
|
(1 219)
|
4 238
|
|
Income to Minority Interest |
91
|
105
|
104
|
111
|
79
|
82
|
89
|
100
|
106
|
120
|
123
|
114
|
|
Net Income (Common) |
(809)
N/A
|
(888)
-10%
|
(1 061)
-19%
|
(1 085)
-2%
|
(845)
+22%
|
(1 095)
-30%
|
(1 178)
-8%
|
(1 245)
-6%
|
(1 009)
+19%
|
(969)
+4%
|
(982)
-1%
|
4 466
N/A
|
|
EPS (Diluted) |
-1.18
N/A
|
-1.29
-9%
|
-1.63
-26%
|
-1.59
+2%
|
-1.26
+21%
|
-1.57
-25%
|
-1.7
-8%
|
-1.74
-2%
|
-1.41
+19%
|
-1.27
+10%
|
-1.27
N/A
|
5.28
N/A
|